/ /

  • linkedin
  • Increase Font
  • Sharebar

    2015 RWAP winner There’s something in the water

    Editor’s Note: Ophthalmology Times is pleased to announce Amy Patel, MD, of Gavin Herbert Eye Institute, UC Irvine Health, Irvine, CA, as the winner of its 2015 Resident Writer’s Award Program, sponsored by Allergan. Dr. Patel’s winning entry is featured here.

    The Ophthalmology Times Resident Writer’s Award Program is a unique recognition opportunity designed to promote excellence in ocular surface disease education. It was created to acknowledge outstanding case identification and written presentation skills in ophthalmology residents.

    This year’s second-place winner is Seanna Grob, MD, MAS, of Massachusetts Eye and Ear, Harvard Medical School, Boston, with her entry, “Management of drug-induced cicatricial conjunctivitis and dry eye.”

    The third-place winner is Amelia Fong, MD, of Georgetown University School of Medicine, Washington, DC, with her entry, “Lifeless limbus.”

    Look for their case study submissions in future issues of Ophthalmology Times.

     

    A 41-year-old male with no significant past medical history initially presented to the eye clinic with a complaint of rapid onset of foreign body sensation, irritation, and eye redness of the right eye for 10 days prior to presentation.

    He reported that he was traveling to Laos and Bangkok when the symptoms began. He was initially evaluated by an ophthalmologist in Bangkok and diagnosed with exacerbation of dry eye syndrome and started on artificial tears and topical steroids.

    When the patient presented to the UC Irvine ophthalmology clinic, he noted that he was having worsening symptomatology despite the previous treatments.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results